Indegene

MME, an Indegene PRMA business, is a global leader in biopharmaceutical pricing, reimbursement, and market access strategy for 25 years.

Indegene is a digital-first life sciences commercialization company, combining deep industry expertise with fit-for-purpose technology to deliver scalable, agile solutions. We help global healthcare organizations achieve efficient clinical, medical, and commercial outcomes—making them future-ready from strategy to execution.

MME provide value-based solutions, payer insights, and GenAI-driven process efficiencies across multiple therapeutic areas, including rare diseases, oncology, and specialty care. Our services span market research, launch readiness, commercial due diligence, and asset valuation for pharma, biotech, and investors.

We routinely support business development and licensing by evaluating pricing and reimbursement potential, risk-sharing models, and market access strategies in the US, EU5, and beyond—helping clients de-risk investments and accelerate clinical-to-commercial success.